Puma Biotechnology Stock Investor Sentiment
| PBYI Stock | USD 3.39 0.16 4.95% |
Under 58% of all Puma Biotechnology's traders are looking to take a long position. The analysis of the overall investor sentiment regarding Puma Biotechnology suggests that some traders are interested. Puma Biotechnology's investing sentiment shows overall attitude of investors towards Puma Biotechnology.
Puma |
Puma Biotechnology Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Puma Biotechnology can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Puma Biotechnology that are available to investors today. That information is available publicly through Puma media outlets and privately through word of mouth or via Puma internal channels. However, regardless of the origin, that massive amount of Puma data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Puma Biotechnology news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Puma Biotechnology relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Puma Biotechnology's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Puma Biotechnology alpha.
Puma Biotechnology Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of 23358 shares by Miller Michael Patrick of Puma Biotechnology at 3.4877 subject to Rule 16b-3 | 09/16/2024 |
2 | SHAREHOLDER ALERT Kaskela Law LLC Announces Investigation - GlobeNewswire | 10/29/2024 |
3 | Acquisition by Jeffrey Ludwig of 66972 shares of Puma Biotechnology subject to Rule 16b-3 | 11/01/2024 |
4 | Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635 | 11/05/2024 |
5 | Puma Biotech Q3 Earnings Snapshot | 11/07/2024 |
6 | PBYI Beats Q3 Earnings Revenue Estimates, Revises 24 View, Stock Up | 11/08/2024 |
7 | Puma Biotechnology Raised to Strong-Buy at StockNews.com | 11/14/2024 |
8 | Puma Biotechnology Announces Initiation of ALISCA-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer | 11/20/2024 |
Complementary Tools for Puma Stock analysis
When running Puma Biotechnology's price analysis, check to measure Puma Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Puma Biotechnology is operating at the current time. Most of Puma Biotechnology's value examination focuses on studying past and present price action to predict the probability of Puma Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Puma Biotechnology's price. Additionally, you may evaluate how the addition of Puma Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Transaction History View history of all your transactions and understand their impact on performance |